GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

At March 31, 2025, the Company had $21.1 million in cash and cash equivalents as compared to $20.3 million in cash and cash ...

FAMAR Group, a leading European pharmaceutical CDMO, is pleased to announce the signature of an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma. The acquisition rep ...

Assertio is a pharmaceutical company with comprehensive commercial ... Assertio's ability to successfully develop and execute its sales, marketing and promotion strategies using its sales force and ...

These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications ...

Q1 2025 Earnings Call Transcript May 9, 2025 Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter ...

Discover key insights from Collegium Pharmaceutical's Q1 2025 earnings call: 23% revenue growth, Jornay PM's market success, sales force expansion & ...

Sales and operating profit growth, significant product acquisition completed, 11 new products, first deal outside Europe and graduation year passed January - March 2025 Consolidated sales during the ...

The heavily pre-treated patients showed median progression-free survival of 29 months, which meant their tumours didn’t get ...

Imre signals a bold new era of client-focused growth with the appointment of Greg Voyles as Chief Growth Officer. This ...

Paysign's patient affordability segment is experiencing rapid growth with higher margins, and is expected to double revenue ...